A Study of Ivonescimab in People With Leiomyosarcoma

NCT07516925 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Leiomyosarcoma

Interventions

DRUG: Ivonescimab

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]